Skip to content
info@ibsgranada.es
FacebookTwitterLinkedInSocial media coordinatorYouTube
ibs logo.GRANADA
  • ibs.GRANADA
  • The Institute
    • The Institute
    • Organizational structure
    • Management Units
    • Economic information
    • Centers
    • Responsible Research and Innovation (RRI)
    • Researcher Area
    • Annual Reports ibs.GRANADA
    • Webmail access
    • Transparency
  • Research
    • Own Plan ibs.GRANADA
    • Research Areas
    • Research groups
    • Clinical research
    • Collaboration network between groups of the ibs.GRANADA
    • Researcher Finder
    • Publications Search
  • Innovation
    • Innovation
    • Technology Offers
    • Clinical practice guidelines
  • international
    • International Projects Unit
    • International Projects
    • International Networks
  • Training
    • Training
    • Research Sessions
    • Conferences and Courses
    • Mentoring Program ibs.GRANADA
    • PhD Programs
    • Official University Master's Degrees
  • News
    • Calls for applications
    • News
    • Events
  • Job vacancies
    • Job vacancies
    • Human Resources Strategy for Researchers of the European Commission (HRS4R)
  • Digital Platforms

A03-Bioactive Molecules

Oncology / IBS-A03 / Consolidated

ibs.GRANADA  ·  Research groups
  • Information
  • Members
  • Patents
  • Publications
  • Projects

The group is dedicated to the design and synthesis of antitumor drugs. The study of the structure-reactivity relationships allows us to refine the structures of the prototypes, increasing the antiproliferative activity and reducing toxicity.

Research lines

  • Homochiral structures obtained from ortho disubstituted benzenes, with antitumor activity
  • New compounds with antitumor activity as choline kinase inhibitors

Keywords

Six- and seven-membered heterocycles, antitumor drugs, purines

ANDRES MARTINEZ MORENO

SOLEDAD ROMERO TAMUDO

JOAQUIN MARIA CAMPOS ROSA

  • ORCID

MERIEM CHAYAH GHADDAB

  • ORCID

MARIA DORA CARRION PILGRIM

  • More Information
  • ORCID

ANA RABBIT GARCIA

  • More Information
  • ORCID

OLGA CRUZ LOPEZ

  • More Information
  • ORCID
Inventors: ARANEGA JIMENEZ ANTONIA; BOULAIZ HOURIA; CAMPOS ROSA JOAQUIN MARIA; CATIVIELA MARIN CARLOS; CHOQUESILLO-LAZARTE DUANE; RABBIT GARCIA ANA; CRUZ LOPEZ OLGA; GARCIA CHAVES MARIA ANGEL; GARCIA RUIZ JUAN MANUEL; JIMENEZ SANZ ANA ISABEL; MARCHAL
Title: BENZOHETEROEPINE TARGETS
Dress: P201030415


Inventors: Campos JM; Lopez l; Marchal JA; Boulaiz H; Aránega A; Rooster MA; Espinosa A; Rodríguez-Serrano F; Rabbit, Ana
Title: NUEVAS (RS) - 7- O 9- (1,2,3,5- TETRAHIDRO-4,1-BENZOCAZEPIN-3-IL) -7H O9H-PURINAS WITH ANTITUMORAL ACTIVITY
Dress: P200802431


Inventors: ARANEGA JIMENEZ ANTONIA; CAMPOS ROSA JOAQUIN; ESPINOSA UBEDA ANTONIO; GALLO MEZO MIGUEL ANGEL; GOMEZ VIDAL JOSE ANTONIO; NUNEZ CARRETERO M DEL CARMEN; MARCHAL CORRALES JUAN ANTONIO; Rodriguez-Serrano F;
Title: (2,3-DIHYDRO-5H-1,4-BENZODIHETEROEPIN-3-IL) PURINES WITH ANTI-TUMOR ACTIVITY
Dress: P200601538
Sanches, VHD; Lobato, CC; Silva, LB; dos Santos, IVF; Barros, ED; Maciel, AD; Ferreira, EFB; da Costa, KS; Espejo-Román, JM; Rosa, JMC; Kimani, N.M.; Santos, C.B.R.

Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the BCR-ABL Gene: An Hierarchical Biochemoinformatics Analysis

PHARMACEUTICALS, 2024;

FI: 4,3; Q1

Chayah, M; Luque-González, A; Gómez-Pérez, V; Salagre, D; Al-Shdaifat, A; Campos, JM; Conejo-García, A; Agil, A

Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats

DRUG DESIGN DEVELOPMENT AND THERAPY, 2024;

FI: 4,7; Q1

Conejo-García, A.; Jiménez-Martínez, Y.; Cámara, R.; Franco-Montalbán, F.; Peña-Martín, J.; Boulaiz, H.; Carrión, M.D.

New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death

BIOORGANIC & MEDICINAL CHEMISTRY, 2024;

FI: 3,3; Q1

Cruz-López, O; Díaz-de-Cerio, E; Rubio-Ruiz, B; Espejo-Román, JM; Peñalver, P; Morales, JC; Caboni, MF; Conejo-García, A; Verardo, V

Hydroxytyrosyl puncate: A first overview of a novel phenolipid with antiproliferative and antitrypanosomal activity

JOURNAL OF FUNCTIONAL FOODS, 2024;

FI: 3,8; Q2

Espejo-Román, JM; Rubio-Ruiz, B; Chayah-Ghaddab, M; Vega-Gutierrez, C; García-García, G; Muguruza-Montero, A; Domene, C; Sánchez-Martín, RM; Cruz-López, O; Conejo-García, A

N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023;

FI: 6,7; Q1

Bastos, RS; de Lima, LR; Net, MFA; Yousaf, N; Cruz, JN; Campos, JM; Kimani, N.M.; Ramos, RS; Santos, C.B.R.

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023;

FI: 5,6; Q1

de Almeida, RBM; Barbosa, DB; do Bomfim, MR; Amparo, JAO; Andrade, BS; Costa, SL; Campos, JM; Cruz, JN; Santos, CBR; Leite, FHA; Botura, MB

Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies

PHARMACEUTICALS, 2023;

FI: 4,6; Q2

Santos, CBR; Lobato, CC; Ota, SSB; Silva, RC; Bittencourt, RCVS; Freitas, JJS; Ferreira, EFB; Ferreira, MB; Silva, RC; De Lima, AB; Campos, JM; Borges, RS; Bittencourt, JAHM

Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions

PHARMACEUTICALS, 2023;

FI: 4,6; Q2

Silva, LB; Ferreira, EFB; Maryam; Espejo-Román, JM; Costa, GV; Cruz, JV; Kimani, N.M.; Costa, JS; Bittencourt, JAHM; Cruz, JN; Campos, JM; Santos, C.B.R.

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

MOLECULES, 2023;

FI: 4,6; Q2

Da Costa, GV; Net, MFA; Da Silva, AKP; DeSa, EMF; Cancela, LCF; Vega, JS; Lobato, CM; Zuliani, JP; Espejo-Roman, JM; Campos, JM; Leite, FHA; Santos, C.B.R.

Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022;

FI: 6,208; Q1

Espejo-Roman, JM; Rubio-Ruiz, B; Cano-Cortes, V; Cruz-Lopez, O; Gonzalez-Resines, S; Domene, C; Conejo-Garcia, A; Sanchez-Martin, RM

Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.

PHARMACEUTICS, 2022;

FI: 6,525; Q1

Net, MFA; Campos, JM; Cerqueira, APM; de Lima, LR; Da Costa, GV; Ramos, RD; Magalhaes, JT; Santos, CBR; Leite, FHA

Hierarchical Virtual Screening and Binding Free Energy Prediction of Potential Modulators of Aedes Aegypti Odorant-Binding Protein 1

MOLECULES, 2022;

FI: 4,927; Q2

Cruz, JV; Rosa, JMC; Kimani, N.M.; Giuliatti, S; dos Santos, CBR

The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases-A Review

CURRENT MEDICINAL CHEMISTRY, 2022;

FI: 4,74; Q2

Arias, F; Camacho, ME; Carrion, MD

NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors

MAGNETIC RESONANCE IN CHEMISTRY, 2022;

FI: 2,392; Q3

Cruz-Lopez, O; Ner, M; Nerin-Fonz, F; Jimenez-Martinez, Y; Araripe, D; Marchal, JA; Boulaiz, H; Gutierrez-de-Terán, H; Campos, JM; Conejo-Garcia, A.

Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021;

FI: 5,051; Q1

Lacal, JC; Zimmerman, T.; Fields, J.M.

Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases

PHARMACEUTICS, 2021;

FI: 6,321; Q1

Days, AD; Dallemole, DR; Bruinsmann, F. A.; Silva, LFL; Cruz-Lopez, O; Conejo-Garcia, A; Battastini, LOVE; Campos, JM; Guterres, SS; Pohlmann, AR; Figueiro, F.

Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

NANOMEDICINE, 2021;

FI: 5,307; Q1

Ferreira, E.F.B.; Silva, L.B.; Cruz, JV; Araujo, P.H.F.; Kimani, NM; Milk, FHA; Campos, JM; Santos, C.B.R.

An Overview of the alpha 4 beta 1 Integrin and the Potential Therapeutic Role of its Antagonists

CURRENT MEDICINAL CHEMISTRY, 2021;

FI: 4,53; Q2

Santos, CBR; Santos, KLB; Cruz, J.N.; Milk, FHA; Borges, RS; Taft, CA; Campos, JM; Silva, CHTP

Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021;

FI:Not Available; Q4

deAndrade, P; Dias, AD; Figueiro, F; Towers, FC; Kawano, D.F.; Battastini, AMO; Carvalho, I; da Silva, CHTD; Fields, JM

1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment towards C6 glioma cell line

FUTURE MEDICINAL CHEMISTRY, 2020;

FI: 3,607; Q2

Palheta, IC; Ferreira, LR; Ok, JKL; Silva, OPP; Herculaneum, AM; Oliveira, KRHM; Neto, AMJC; Campos, JM; Santos, CBR; Borges, RS

Alkylated Sesamol Derivatives as Potent Antioxidants

MOLECULES, 2020;

FI: 3,267; Q2

dos Santos, KLB; Cross, JN; Silva, L.B.; Ramos, RS; Net, MFA; Lobato, C.C.; Ota, SSB; Leite, FHA; Borges, RS; da Silva, CHTP; Fields, JM; Santos, CBR

Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches

MOLECULES, 2020;

FI: 3,267; Q2

Araujo, PHF; Ramos, RS; da Cruz, JN; Silva, SG; Ferreira, EFB; from Lima, LR; Macedo, WJC; Mirror-Roman, JM; Campos, JM; Santos, CBR

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches.

MOLECULES, 2020;

FI: 3,267; Q2

Romagnoli, R; Oliva, P; Salvador, MK; Camacho, ME; Padroni, C; Brancale, A; Ferla, S; Hamel, E; Snore; Grillo, E; Bortolozzi, R; Rruga, F; Mariotto, E; Viola, G

Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019;

FI: 4,833; D1

Bittencourt, JAHM; Net, MFA; Lacerda, PS; Bittencourt, RCVS; Silva, RC; Lobato, C.C.; Silva, L.B.; Leite, FHA; Zuliani, J.P.; Pink, JMC; Borges, RS; Santos, CBR

In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity

MOLECULES, 2019;

FI: 3,06; Q2

Borges, RS; Palheta, IC; Ota, SSB; Morais, R.B.; Muds, VA; Ramos, RS; Silva, RC; Coast, J.D.; Silva, CHTP; Fields, JM; Santos, CBR

Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism

MOLECULES, 2019;

FI: 3,06; Q2

Ferreira, EFB; Silva, L.B.; Coast, G.V.; Coast, JS; Fujishima, MAT; Leao, R.P.; Ferreira, ALS; Frederick, L.B.; Silva, CHTP; Pink, JMC; Macedo, WJC; Santos, CBR

Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening

MOLECULES, 2019;

FI: 3,06; Q2

Fernandez-Saez, N; Fields, JM; Camacho, ME; Carrion, MD

NMR studies of new heterocycles tethered to purine moieties with anticancer activity

MAGNETIC RESONANCE IN CHEMISTRY, 2019;

FI: 1,731; Q3

Ramirez, A; Rabbit-Garcia, A; Grinan-Lison, C; Lopez-Cara, LC; Jimenez, G; Fields, JM; Marchal, J.A.; Boulaiz, H.

Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells

FRONTIERS IN PHARMACOLOGY, 2018;

FI: 3,831; Q1

Del Ponte, G; Archanjo, FC; Watanabe, L.Y.; Donate, PM; Fields, JM

Syntheses of non-aromatic medium and large rings synthesized via phenylnitrenium ions

ARABIAN JOURNAL OF CHEMISTRY, 2018;

FI: 2,969; Q2

Mahfoudh, N; Marin-Ramos, NI; Gil, AM; Jimenez, AI; Choquesillo-Lazarte, D; Kawano, D.F.; Fields, JM; Cativiela, C.

Cysteine-based 3-substituted 1,5-benzoxathiepin derivatives: Two new classes of anti-proliferative agents

ARABIAN JOURNAL OF CHEMISTRY, 2018;

FI: 2,969; Q2

Gonzalez-Martinez, D; Fernandez-Saez, N; Cativiela, C; Fields, JM; Gotor-Fernandez, V.

Development of Biotransamination Reactions towards the 3,4-Dihydro-2H-1,5-benzoxathiepin-3-amine Enantiomers

CATALYSTS, 2018;

FI: 3,465; Q2

Costa, JD; Ramos, RD; Costa, KDL; Brazil, DDB; da Silva, CHTD; Ferreira, EFB; Borges, RD; Campos, JM; Macedo, WJD; dos Santos, CBR

An In Silico Study of the Antioxidant Ability for Two Caffeine Analogs Using Molecular Docking and Quantum Chemical Methods

MOLECULES, 2018;

FI: 3,098; Q2

Cruz-Lopez, O; Ramirez, A; Navarro, SA; Garcia, MA; Marchal, JA; Campos, JM; Rabbit-Garcia, A

1- (Benzenesulfonyl) -1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds

FUTURE MEDICINAL CHEMISTRY, 2017;

FI: 3,556; Q1

Morales, F; Ramirez, A; Morata-Tarifa, C; Navarro, SA; Marchal, JA; Campos, JM; Rabbit-Garcia, A

Antitumor activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells

FUTURE MEDICINAL CHEMISTRY, 2017;

FI: 3,556; Q1

Camacho, ME; Carrion, M.D.; Chayah, M; Fields, JM

The use of wiki to promote students' learning in higher education (Degree in Pharmacy)

INTERNATIONAL JOURNAL OF EDUCATIONAL TECHNOLOGY IN HIGHER EDUCATION, 2016;

Serran-Aguilera, L; Denton, H; Rubio-Ruiz, B; Lopez-Gutierrez, B; Train, A; Left, L; Smith, TK; Conejo-Garcia, A; Hurtado-Guerrero, R

Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death

SCIENTIFIC REPORTS, 2016;

FI: 5,228; Q1

Garcia-Rubino, ME; Lozano-Lopez, C; Fields, JM

Inhibitors of Cancer Stem Cells

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016;

FI: 2,722; Q2

Gonzalez-Perez, JM; Choquesillo-Lazarte, D; Dominguez-Martin, A; Vilchez-iodriguez, E; Perez-Toro, I; Castineiras, A; Arriortua, OK; Garcia-Rubino, ME; Matilla-Hernandez, A; Niclos-Gutierrez, J.

Metal binding pattern of acyclovir in ternary copper (II) complexes having an S-thioether or S-disulfide NO2S-tripodal tetradentate chelator

INORGANIC CHEMISTRY ACT, 2016;

FI: 1,918; Q2

Morales, F; Campos, JM; Rabbit-Garcia, A

H-1 and C-13 NMR spectral data of p-nitrobenzenesulfonamides and dansylsulfonamides derived from N-alkylated o- (purinemethyl) anilines

MAGNETIC RESONANCE IN CHEMISTRY, 2016;

FI: 1,226; Q3

Towers, FC; Garcia-Rubino, ME; Lozano-Lopez, C; Kawano, D.F.; Eifler-Lima, VL; von Poser, G.L.; Fields, JM

Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy

CURRENT MEDICINAL CHEMISTRY, 2015;

FI: 3,853; D1

Gomez-Perez, V; Manzano, J. I.; Garcia-Hernandez, R; Castanys, S; Gamarro, F; Fields, JM

Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015;

FI: 3,447; Q1

Morales, F; Rabbit-Garcia, A; Ramirez, A; Morata, C; Marchal, J.A.; Fields, JM

p-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o- (purine-methyl) anilines as novel antitumor agents

CSR ADVANCES, 2015;

FI: 3,84; Q1

Lacal, JC; Fields, JM

Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells

MOLECULAR CANCER THERAPEUTICS, 2015;

FI: 5,683; Q1

Gonzalez-Perez, JM; Choquesillo-Lazarte, D; Dominguez-Martin, A; El Bakkali, H; Garcia-Rubino, ME; Perez-Toro, I; Vilchez-Rodriguez, E; Castineiras, A; Nurchi, VM; Niclos-Gutierrez, J.

Molecular recognition between adenine or 2,6-diaminopurine and copper (II) chelates with N, O-2, S-tripodal tetradentate chelators having thioether or disulfide donor groups

JOURNAL OF INORGANIC BIOCHEMISTRY, 2015;

FI: 3,444; Q1

Design, synthesis, biological evaluation and targeted release of CD44 inhibitors: a promising antitumor therapy

Funder: COUNCIL OF ECONOMIC TRANSFORMATION, INDUSTRY, KNOWLEDGE AND UNIVERSITIES

File number: P18-RT-1679

Execution time: 01/01/2020 - 31/03/2023

IP: ANA CONEJO GARCIA

Synthesis of lipophenols with anticancer activity from bioactive compounds from food by products

Funder: STATE RESEARCH AGENCY

File number: TED2021-132047B-I00

Execution time: 01/12/2022 - 30/11/2024

IP: ANA CONEJO GARCIA

Development of a new nanotechnology platform for antitumor therapy based on CD44 inhibition

Funder: STATE RESEARCH AGENCY

File number: PID2021-128109OB-I00

Execution time: 01/09/2022 - 31/08/2025

IP: ANA CONEJO GARCIA

Improvement of the anticancer activity of bozepinib, bozinib and derivatives, through the introduction of the trifluoromethyl group

Funder: UNIVERSITY OF GRANADA

File number: CS2016-1

Execution time: 01/01/2017 - 31/10/2018

PI: JOAQUIN MARIA CAMPOS ROSA

facebook icon twitter icon LinkedIn icon whatsapp icon

Responsible researcher

ANA RABBIT GARCIA

  • aconejo@ugr.es
  • More Information
  • ORCID

Responsible Co-Investigator

OLGA CRUZ LOPEZ

  • olgacl@ugr.es
  • More Information
  • ORCID

Research

  • Collaboration network between groups of the ibs.GRANADA
  • Oncology Area
  • Epidemiology and Public Health Area
  • Precision Medicine Area
  • Advanced Therapies and Biomedical Technologies Area
  • Clinical Trials Platform

Post navigation

A02-Take care: Oncology Care and Advances in Sports Medicine
A04-Digital and Computational Pathology, Immunopathology and Cancer

ibs.Granada logo

  • info@ibsgranada.es
  • Avda. De Madrid, 15
    External Consultation Pavilion, 2nd Floor
    18012 Grenada.
  • facebook icon
  • twitter icon
  • instagram icon
  • linkedin icon
  • youtube icon
University of Granada
Investigate +
© 2026 ibs.GRENADA
  • Legal Notice
  • Cookies Policy
  • Privacy Policy
  • Contact
  • Site map

We use cookies to offer you the best experience on our website.

You can learn more about which cookies we use or deactivate them in the .

X
ibs logo.GRANADA
Powered by  GDPR Cookie Compliance
Privacy summary

This website uses cookies so that we can offer you the best possible user experience. The information of the cookies is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.

Technical and necessary cookies

The strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

Analytics and optimization

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Cookie policy

More information about our Cookies policy